Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
fluconazole · 5 trials · 6 indications
Therapeutic outcome was determined by combination of clinical efficacy and mycological efficacy for each participant as Effective, Ineffective or Indeterminate. The therapeutic outcome was considered as Effective when the clinical efficacy was Cure and the mycological efficacy was Eradication. Primary evaluation of therapeutic outcome was on Day 28. Response rate was calculated based on the following formula, "the number of participants assessed as effective" over "total participants excluding ones assessed as indeterminate" multiplied by 100.
| Arm | Type | Description |
|---|---|---|
| Fluconazole | EXPERIMENTAL | - |
| Arm A | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| Fluconazole | DRUG | Single oral dose of 150mg Fluconazole |
| Amphotericin B | DRUG | - |
Inclusion Criteria: * Patients with clinical symptoms and signs of vulvovaginal candidiasis. * Patients tested positive for Candida by fungal culture. * Patients who can agree not to have intercourse up to 28 days after dosing. Exclusion Criteria: * Patients with a history of hypersensitivity to ...